Award
NIH Reporter #3U01AI172853-04S2
Development of a Novel Therapeutic for Mitigating Radiation-Induced Microbiome Dysbiosis and Acute Gastrointestinal Syndrome
Recipient
Columbia University Health Sciences
Award Amount
$48,754.00
Ceiling
$48,754.00
Awarded
August 19, 2026
Identifier
3U01AI172853-04S2
NIH awarded Columbia University $48,754 to develop MIIST305, a novel therapeutic to counteract radiation-induced gastrointestinal syndrome by preserving gut microbiota and reducing inflammation, with the goal of FDA approval.
Description
Development of a novel GI-targeted therapeutic drug (MIIST305) to mitigate radiation-induced gastrointestinal injury by maintaining gut microbiota balance and reducing inflammation, aiming for FDA approval as a medical countermeasure.